ProQR Therapeutics N.V Profit Margin

The latest profit margin for PRQR is -228.38% as of June 2026. That compares with -240.63% in the prior-year period — up 5.1% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside ProQR Therapeutics N.V's historical trend and sector peers before judging valuation or financial health.

Over the past year, PRQR's profit margin moved from -240.63% to -228.38% — a 5.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ProQR Therapeutics N.V's valuation or profitability profile.

Against Healthcare companies, PRQR currently prints -228.38% for profit margin, while the sector average sits near 13.89%. That is roughly 1744.8% below the sector mean. Large gaps often invite a closer look at ProQR Therapeutics N.V's growth, margins, and balance sheet.

Profit Margin shows how effectively ProQR Therapeutics N.V converts resources into returns. At -228.38%, PRQR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -240.63% in the prior-year period — up 5.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PRQR's profit margin (-228.38%), review year-over-year change from -240.63%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.